Growing government and private funding for single-cell analysis research activities contributes to the growth of the market in the forecast period

According to the report, the Single-Cell Analysis market is anticipated to reach US$ 6.5 Bn in 2025 at a CAGR of 15.4% from 2017 to 2025. The report provides detailed analysis of the current and emerging trends in the Single-cell analysis market. The market size and volume has been provided for product, and end-user segments. Based on product, the market has been segmented into instruments and consumables. Based on end user, the market has been segmented into hospitals, diagnostic centers, research labs, biotechnology and bio-pharmaceutical companies, and others. The report provides forecasts for revenue (US$ Mn) of the product and end user during 2017–2025.

Read Report - https://www.transparencymarketresearch.com/single-cell-analysis-market.html

Based on product type, the market has been segmented into instruments and consumables. The instruments include cell counters, spectrophotometers, sequencers, cytometers, imaging systems, PCR, and others. The consumables include reagents and kits, micropipettes and micro plates, and others. The consumables were the growth driving segment in 2016 and are anticipated to remain dominant during the forecast period, growing at a significantly high CAGR. The growth of the consumables can be attributed to the continuous demand for and the repeat purchase of consumables. Among the consumables reagents and kits are anticipated to be the leading revenue generating segment. Among the instruments, cytometers dominated the market in terms of revenues in 2017 and are anticipated to remain dominant owing to their ability to accurately isolate single cells primarily via fluorescence assisted flow cytometry (FACS).

Inquire for a Sample Copy of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10565

In addition, these devices are also employed for analysis purposes, integrating the processes of isolation and analysis to ease the research process. However, sequencers are anticipated to grow at a very high CAGR during the forecast period, owing to the spurring demand for next-generation sequencing for single-cell analysis on account of the accuracy of these procedures. This is anticipated to be followed by PCR segment. Their growth is being driven by the growing applications of real-time and digital PCR systems in single-cell analysis, the accuracy of analysis provided by them, and their ability to interpret the results with no errors. In addition, the adoption of digital PCR has been increasing owing to their ability to amplify rare alleles which might be present in low copies of the test sample, and contribute to the increased precision & quantification of the sample, and providing better analysis results, among others.

Research labs segment was the largest segment in 2016. It is anticipated to maintain in dominance in the forecast period and record a high CAGR growth. This is attributed to the growing research in the field of genomics and proteomics which are the primary application segments of single-cell analysis. In addition, the strong focus on the development of new platforms to enhance the process of single-cell analysis, development of new assay kits for the detection of various infectious diseases and cancer; growing government funding for research activities; and increasing applications of single-gene analysis, among others contribute to the growth of the market. This segment is anticipated to be followed by biotechnology and bio-pharmaceutical companies.

Download a PDF Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10565

Increase in the number of biotechnology companies, surging investments in R&D to develop single-cell assay kits for the identification of infectious diseases and cancerous growth, and rising demand for IVF kits drive the segment. For instance, the number of biotechnology companies in Germany increased to over 700 in 2015. Similarly, Japan and Singapore are the growing hubs of biotechnology companies. Furthermore, the market players are entering into collaborations for the development of new platforms for single-cell analysis which would aid in the market growth.

Major players in the Single-Cell Analysis market include Thermo Fisher Scientific, Inc., WaferGen Bio-systems, Inc., Becton, Dickinson and Company, Fluidigm Corporation, Eppendorf AG, QIAGEN N.V., NuGEN Technologies, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., and 10x Genomics among others. The market players adopted the inorganic growth strategy to enhance their market position in the single-cell analysis market. In addition, the players also entered into strategic distribution partnerships primarily in Asia Pacific and Middle East to enhance their product offerings for the customers.

Purchase this Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=10565

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.